Carbonic anhydrases III and IV autoantibodies in rheumatoid arthritis, systemic lupus erythematosus, diabetes, hypertensive renal disease, and heart failure

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Liu, Chengeng ^a   Wei, Yue ^b   Wang, Jianmin ^c   Pi, Langan ^c   Huang, Jianjun ^c   Wang, Peichang ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^c Central South University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CARBONIC ANHYDRASE III AUTOANTIBODY; CARBONIC ANHYDRASE IV AUTOANTIBODY; CATALASE; GAMMA INTERFERON; GLUTATHIONE PEROXIDASE; INTERLEUKIN 17; INTERLEUKIN 6; MALONALDEHYDE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIOXIDANT; CARBONATE DEHYDRATASE III; CARBONATE DEHYDRATASE IV;

ADULT; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME REPRESSION; FEMALE; HEART FAILURE; HUMAN; HYPERTENSIVE NEPHROPATHY; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TYPE 1 DIABETIC NEPHROPATHY; TYPE 2 DIABETIC NEPHROPATHY; AGED; IMMUNOLOGY; METABOLISM; MIDDLE AGED; NEPHRITIS; RENOVASCULAR HYPERTENSION;

ADULT; AGED; ANTIOXIDANTS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CARBONIC ANHYDRASE III; CARBONIC ANHYDRASE IV; DIABETES MELLITUS, TYPE 1; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION, RENAL; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-6; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NEPHRITIS; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84867381427     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/354594     Document Type: Article

References (27)

1. Martínez-Borra J., López-Larrea C., Autophagy and self-defense. Advances in Experimental Medicine and Biology 2012 738 169 184
2. Kaya Z., Leib C., Katus H. A., Autoantibodies in heart failure and cardiac dysfunction. Circulation Research 2012 110 1 145 158 10.1161/CIRCRESAHA.111.243360
3. Supuran C. T., Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nature Reviews Drug Discovery 2008 7 2 168 181 2-s2.0-38849143765 10.1038/nrd2467 (Pubitemid 351194064)
4. Sherer Y., Gorstein A., Fritzler M. J., Shoenfeld Y., Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Seminars in Arthritis and Rheumatism 2004 34 2 501 537 2-s2.0-14244250736 10.1016/j.semarthrit.2004.07.002 (Pubitemid 40288129)
5. Hosoda H., Okawa-Takatsuji M., Shinmura W., Hasimoto N., Ozaki Y., Ikeda Y., Potential for differential diagnosis of autoimmune pancreatitis and pancreatic cancer using carbonic anhydrase II antibody. Pancreas 2008 37 1 e1 e7 2-s2.0-49649101839 10.1097/MPA.0b013e318162cb3a
6. Sánchez-Castaón M., de las Heras-Castao G., López-Hoyos M., Autoimmune pancreatitis: an underdiagnosed autoimmune disease with clinical, imaging and serological features. Autoimmunity Reviews 2010 9 4 237 240 2-s2.0-73749088313 10.1016/j.autrev.2009.07.003
7. Räisänen S. R., Lehenkari P., Tasanen M., Rahkila P., Härkönen P. L., Väänänen H. K., Carbonic anhydrase III protects cells from hydrogen peroxide-induced apoptosis. FASEB Journal 1999 13 3 513 522 2-s2.0-0345003848 (Pubitemid 29115569)
8. Zimmerman U. J. P., Wang P., Zhang X., Bogdanovich S., Forster R. E., Anti-oxidative response of carbonic anhydrase III in skeletal muscle. IUBMB Life 2004 56 6 343 347 2-s2.0-7044222509 10.1080/1521-6540400000850 (Pubitemid 39423142)
9. Schwartz G. J., Olson J., Kittelberger A. M., Matsumoto T., Waheed A., Sly W. S., Postnatal development of carbonic anhydrase IV expression in rabbit kidney. American Journal of Physiology 1999 276 4, part 2 F510 F520 2-s2.0-0032935767 (Pubitemid 29217380)
10. Breton S., The cellular physiology of carbonic anhydrases. Journal of the Pancreas 2001 2 4 159 164 2-s2.0-0035411026 (Pubitemid 38963844)
11. Vaughan-Jones R. D., Spitzer K. W., Swietach P., Spatial aspects of intracellular pH regulation in heart muscle. Progress in Biophysics and Molecular Biology 2006 90 13 207 224 2-s2.0-23744511650 10.1016/j.pbiomolbio. 2005.06.004 (Pubitemid 41721052)
12. Li W., Wang W., Sun S., Autoantibodies against the catalytic domain of BRAF are not specific serum markers for rheumatoid arthritis. PLoS One 2011 6 12, article e28975
13. Alver A., entürk A., akirbay H., Carbonic anhydrase II autoantibody and oxidative stress in rheumatoid arthritis. Clinical Biochemistry 2011 44 17-18 1385 1389
14. Biswas U. K., Kumar A., Study on the changes of carbonic anhydrase activity in insulin resistance and the effect of methylglyoxal. Journal of the Pakistan Medical Association 2012 62 5 417 421
15. Sanyal G., Swenson E. R., Pessah N. I., Maren T. H., The carbon dioxide hydration activity of skeletal muscle carbonic anhydrase. Inhibition by sulfonamides and anions. Molecular Pharmacology 1982 22 1 211 220 2-s2.0-0019953175 (Pubitemid 12097284)
16. Mitterberger M. C., Kim G., Rostek U., Carbonic anhydrase III regulates peroxisome proliferator-activated receptor- γ 2. Experimental Cell Research 2012 318 8 877 886
17. Carrière A., Carmona M. C., Fernandez Y., Rigoulet M., Wenger R. H., Pénicaud L., Casteilla L., Mitochondrial reactive oxygen species control the transcription factor CHOP-10/GADD153 and adipocyte differentiation: a mechanism for hypoxia-dependent effect. Journal of Biological Chemistry 2004 279 39 40462 40469 2-s2.0-4644329647 10.1074/jbc.M407258200 (Pubitemid 39287636)
18. Stanton L. W., Ponte P. A., Coleman R. T., Snyder M. A., Expression of CA III in rodent models of obesity. Molecular Endocrinology 1991 5 6 860 866 2-s2.0-0026001075 (Pubitemid 21923741)
19. Piganelli J. D., Delmastro M. M., Oxidative stress and redox modulation potential in type 1 diabetes. Clinical and Developmental Immunology 2011 2011 15 2-s2.0-79959200769 10.1155/2011/593863 593863
20. Arcidiacono B., Iiritano S., Nocera A., Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms. Experimental Diabetes Research 2012 2012 12 789174 10.1155/2012/789174
21. McCord J. M., Edeas M. A., SOD, oxidative stress and human pathologies: a brief history and a future vision. Biomedicine and Pharmacotherapy 2005 59 4 139 142 2-s2.0-18044363639 10.1016/j.biopha.2005.03.005 (Pubitemid 40603324)
22. Cabiscol E., Levine R. L., The phosphatase activity of carbonic anhydrase III is reversibly regulated by glutathiolation. Proceedings of the National Academy of Sciences of the United States of America 1996 93 9 4170 4174 2-s2.0-0030008246 10.1073/pnas.93.9.4170 (Pubitemid 26146729)
23. Arcidiacono B., Iiritano S., Nocera A., Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms. Experimental Diabetes Research 2012 2012 789174
24. Yamada H., Current perspectives on the role of IL-17 in autoimmune disease. Journal of Inflammation Research 2010 3 1 33 44 2-s2.0-77955538624
25. Lorenzo N., Barberá A., Domínguez M. C., Therapeutic effect of an altered peptide ligand derived from heat shock protein 60 by suppressing of inflammatory cytokines secretion in two animal models of rheumatoid arthritis. Autoimmunity 2012 45 6 449 459
26. Cua D. J., Sherlock J., Chen Y., Murphy C. A., Joyce B., Seymour B., Lucian L., To W., Kwan S., Churakova T., Zurawski S., Wiekowski M., Lira S. A., Gorman D., Kastelein R. A., Sedgwick J. D., Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003 421 6924 744 748 2-s2.0-0037434789 10.1038/nature01355 (Pubitemid 36227625)
27. Sanyal G., Swenson E. R., Pessah N. I., Maren T. H., The carbon dioxide hydration activity of skeletal muscle carbonic anhydrase. Inhibition by sulfonamides and anions. Molecular Pharmacology 1982 22 1 211 220 2-s2.0-0019953175 (Pubitemid 12097284)